Real Endpoints Appoints Jeff Berkowitz, CEO and Director
September 13, 2018 11:14 ET
|
Real Endpoints
MADISON, N.J., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Real Endpoints (RE), a leader in the development and implementation of proprietary tools to strengthen pharmaceutical market access for an evolving...
Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
February 20, 2018 10:00 ET
|
Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
Top Pharma Companies Nurture Relationships with Payers Before, During and After Launch to Ensure and Retain Market Access
July 24, 2017 18:54 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 24, 2017) - Payer relationship management accounts for an average of 26% of surveyed global pharmaceutical and medical device companies' total market...
Pharmaceutical Launch Sequencing Trends: Designing Each Product Launch Sequence From Scratch
July 05, 2017 18:53 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - July 05, 2017) - About 81% of surveyed Top 10, Top 50, and small pharmaceutical and medical device firms build launch sequences from scratch for each...
Global Pharma Companies Begin Conducting Comparative Effectiveness Research During Phase 3 of Product Development
June 26, 2017 21:08 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 26, 2017) - Research from global market access teams found that pharmaceutical and medical device companies often wait until Phase 3 or later to...
Zephyr Health and Decision Resources Group (DRG) Maximize Value of Formulary Data for Life Sciences Commercial Teams
June 12, 2017 07:00 ET
|
Zephyr Health
BURLINGTON, Mass. and SAN FRANCISCO, June 12, 2017 (GLOBE NEWSWIRE) -- Zephyr Health, the leading Insights-as-a-Service solution provider for Life Sciences companies, and Decision Resources Group...
Brazil, Russia, India, and China (BRIC) Becoming Popular Second Wave Targets, Recent Study Finds
May 10, 2017 15:30 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - May 10, 2017) - Emerging markets such as Brazil and India are becoming common second wave targets for pharmaceutical product launches, according to a recent...
Zephyr Health Report Reveals Important Opportunities for Pharma Brand Success
April 10, 2017 08:00 ET
|
Zephyr Health
SAN FRANCISCO, April 10, 2017 (GLOBE NEWSWIRE) -- Today Zephyr Health, the leading Insights-as-a-Service company, released a report entitled “Powering the Life Sciences Commercial Engine with Market...
DRG and Zephyr Health Announce Partnership to Optimize the Commercial and Market Access Experience for Pharma Stakeholders
November 29, 2016 06:00 ET
|
Zephyr Health; Decision Resources Group
BURLINGTON, Mass. and SAN FRANCISCO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Decision Resources Group (DRG), a leading provider of proprietary data products and solutions to the healthcare industry, and...
Pharmaceutical Companies Targeting Major Western Markets for New Drug Launches
September 14, 2016 08:08 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2016) - A recent study found that 74% of surveyed drug companies market new products in the US during their first launch wave. During this same...